153 related articles for article (PubMed ID: 26095919)
21. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A
Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304
[TBL] [Abstract][Full Text] [Related]
22. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
Krobert K; Lopez-Colberg I; Cunningham LA
Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
[TBL] [Abstract][Full Text] [Related]
23. Cell death mechanisms in Parkinson's disease.
Jellinger KA
J Neural Transm (Vienna); 2000; 107(1):1-29. PubMed ID: 10809400
[TBL] [Abstract][Full Text] [Related]
24. Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria.
Schmidt S; Linnartz B; Mendritzki S; Sczepan T; Lübbert M; Stichel CC; Lübbert H
Hum Mol Genet; 2011 Mar; 20(6):1197-211. PubMed ID: 21212098
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
26. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
27. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
[TBL] [Abstract][Full Text] [Related]
28. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
29. DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age.
Mullett SJ; Hamilton RL; Hinkle DA
Neuropathology; 2009 Apr; 29(2):125-31. PubMed ID: 18647263
[TBL] [Abstract][Full Text] [Related]
30. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
31. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.
Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM
Mov Disord; 2015 Oct; 30(12):1639-47. PubMed ID: 25594542
[TBL] [Abstract][Full Text] [Related]
32. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
33. From proliferative to neurological role of an hsp70 stress chaperone, mortalin.
Deocaris CC; Kaul SC; Wadhwa R
Biogerontology; 2008 Dec; 9(6):391-403. PubMed ID: 18770009
[TBL] [Abstract][Full Text] [Related]
34. Novel role of mortalin in attenuating HIV-1 Tat-mediated astrogliosis.
Priyanka ; Wadhwa R; Chaudhuri R; Nag TC; Seth P
J Neuroinflammation; 2020 Sep; 17(1):276. PubMed ID: 32951595
[TBL] [Abstract][Full Text] [Related]
35. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
36. Modulation of connexin 43 in rotenone-induced model of Parkinson's disease.
Kawasaki A; Hayashi T; Nakachi K; Trosko JE; Sugihara K; Kotake Y; Ohta S
Neuroscience; 2009 Apr; 160(1):61-8. PubMed ID: 19232380
[TBL] [Abstract][Full Text] [Related]
37. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.
Nagel F; Falkenburger BH; Tönges L; Kowsky S; Pöppelmeyer C; Schulz JB; Bähr M; Dietz GP
J Neurochem; 2008 May; 105(3):853-64. PubMed ID: 18182047
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotic drug use is correlated with CRP40/mortalin mRNA expression in the dorsolateral prefrontal cortex of human postmortem brain specimens.
Gabriele JP; Pontoriero GF; Thomas N; Ferro MA; Mahadevan G; MacCrimmon DJ; Pristupa ZB; Mishra RK
Schizophr Res; 2010 Jun; 119(1-3):228-31. PubMed ID: 20100649
[TBL] [Abstract][Full Text] [Related]
39. Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
Sun H; Liang R; Yang B; Zhou Y; Liu M; Fang F; Ding J; Fan Y; Hu G
Neuroscience; 2016 Mar; 317():65-75. PubMed ID: 26774050
[TBL] [Abstract][Full Text] [Related]
40. Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model.
Lazzarini M; Martin S; Mitkovski M; Vozari RR; Stühmer W; Bel ED
Glia; 2013 Jul; 61(7):1084-100. PubMed ID: 23595698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
